NCT04455737View on ClinicalTrials.gov

Ex Vivo Intra-arterial Indigo Carmine Injection After Transanal Total Mesorectal Excision

CompletedOBSERVATIONAL
Enrollment

189

Participants

Timeline

Start Date

October 31, 2013

Primary Completion Date

December 31, 2019

Study Completion Date

June 30, 2020

Conditions
Rectal Neoplasms
Interventions
OTHER

injection of indigo carmine

Ex vivo intra-arterial injection of 20 ml indigo carmine solution (10mL, 0.4% indigo carmine with 10mL, 0.9% saline solution) in the transanal total mesorectal excision specimen via the inferior mesenteric artery.

Trial Locations (1)

9400

Department of General, Visceral, Endocrine and Transplantation Surgery, Cantonal Hospital St. Gallen, Rorschach

All Listed Sponsors
lead

Walter Brunner

OTHER

NCT04455737 - Ex Vivo Intra-arterial Indigo Carmine Injection After Transanal Total Mesorectal Excision | Biotech Hunter | Biotech Hunter